4.22
price down icon0.94%   -0.04
after-market アフターアワーズ: 4.32 0.10 +2.37%
loading

Voyager Therapeutics Inc (VYGR) 最新ニュース

pulisher
Feb 21, 2025

VYGR Investors Have Opportunity to Join Voyager Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Morningstar

Feb 21, 2025
pulisher
Feb 21, 2025

Levi & Korsinsky Reminds Voyager Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsVYGR - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 21, 2025

Lost Money on Voyager Therapeutics, Inc. (VYGR)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Feb 21, 2025
pulisher
Feb 20, 2025

Voyager Therapeutics (VYGR) to Release Quarterly Earnings on Wednesday - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Kirby McInerney LLP Announces Investigation Against Voyager Therapeutics, Inc. (VYGR) on Behalf of Investors - GlobeNewswire Inc.

Feb 19, 2025
pulisher
Feb 19, 2025

Voyager Therapeutics stock hits 52-week low at $4.12 By Investing.com - Investing.com Nigeria

Feb 19, 2025
pulisher
Feb 19, 2025

Voyager Therapeutics reassesses SOD1-ALS gene therapy program - ALS News Today

Feb 19, 2025
pulisher
Feb 19, 2025

Wedbush Has Bearish Estimate for VYGR FY2025 Earnings - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc.VYGR - PR Newswire

Feb 18, 2025
pulisher
Feb 17, 2025

Research Analysts Set Expectations for VYGR FY2029 Earnings - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Wedbush Predicts Lower Earnings for Voyager Therapeutics - Armenian Reporter

Feb 16, 2025
pulisher
Feb 15, 2025

Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Voyager Therapeutics (NASDAQ:VYGR) Receives "Outperform" Rating from Wedbush - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Equities Analysts Issue Forecasts for VYGR FY2025 Earnings - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Voyager Therapeutics COO Robin Swartz sells $30,927 in stock - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

Brokers Issue Forecasts for VYGR FY2029 Earnings - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

A company insider recently sold 5,413 shares of Voyager Therapeutics Inc [VYGR]. Should You Sale? - Knox Daily

Feb 13, 2025
pulisher
Feb 13, 2025

Voyager Therapeutics COO Robin Swartz sells $30,927 in stock By Investing.com - Investing.com Australia

Feb 13, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics' chief legal officer sells $19,393 in stock - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics CEO Alfred Sandrock sells $74,065 in stock By Investing.com - Investing.com Australia

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics’ chief legal officer sells $19,393 in stock By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics stock hits 52-week low at $4.12 - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics' chief scientific officer sells shares worth $24,087 - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics’ chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com Nigeria

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics' chief scientific officer sells shares worth $24,087 By Investing.com - Investing.com South Africa

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics' chief legal officer sells $19,393 in stock By Investing.com - Investing.com UK

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics Executives Sell Shares - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics, Inc. (VYGR): A Cheap Biotech Stock to Invest In Now - Insider Monkey

Feb 12, 2025
pulisher
Feb 12, 2025

Insiders Sold Voyager Therapeutics Prematurely At US$7.47 With Stock Trading Higher - Simply Wall St

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager updates on SOD1 ALS gene therapy program - The Pharma Letter

Feb 12, 2025
pulisher
Feb 12, 2025

Voyager Therapeutics (NASDAQ:VYGR) Given “Outperform” Rating at Wedbush - Defense World

Feb 12, 2025
pulisher
Feb 12, 2025

SG Americas Securities LLC Increases Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World

Feb 12, 2025
pulisher
Feb 12, 2025

10 Cheap Biotech Stocks to Invest in Now - Insider Monkey

Feb 12, 2025
pulisher
Feb 11, 2025

Voyager Therapeutics shifts focus for ALS therapy - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Voyager Therapeutics stock tumbles after IND application delayed - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Voyager Therapeutics stock tumbles after IND application delayed By Investing.com - Investing.com Canada

Feb 11, 2025
pulisher
Feb 11, 2025

Voyager Therapeutics shifts focus for ALS therapy By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 11, 2025

Wedbush Adjusts Price Target on Voyager Therapeutics to $9 From $11, Maintains Outperform Rating - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

Voyager Provides Update on SOD1 ALS Gene Therapy Program - GlobeNewswire

Feb 11, 2025
pulisher
Feb 11, 2025

Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload - Fierce Biotech

Feb 11, 2025
pulisher
Feb 11, 2025

Voyager Therapeutics Shares Fall After Dropping Plan for VY9323 IND Filing in Mid-2025 - Marketscreener.com

Feb 11, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):